Israel Ortega Sánchez, M.D., Ph.D.
Gynecologist and Reproductive Medicine Specialist at IVI Madrid
IVI Madrid
Israel Ortega Sánchez, M.D., Ph.D.
Biography
Dr. Israel Ortega graduated from Complutense University School of Medicine in 2004 and received his Obstetrics and Gynecology Board certification from Autonoma University, Hospital La Paz in 2009. He is been working as a consultant in Reproductive Medicine at Instituto Valenciano de Infertilidad (IVI) since 2009. From 2010 to 2011 he studied at University of California, Davis (USA), under a Reproductive Endocrinology and Infertility Fellowship, receiving his PhD in 2014.
Read more
Education and Training
| M.D. | Complutense University of Madrid Medical School, Madrid, Spain (2004) |
| Residency in Obstetrics and Gynecology | La Paz Hospital, Madrid, Spain (2004) |
| Expert Degree in Clinical Genetics | Alcala de Henares University, Madrid (2009) |
| Postdoctoral Fellowship: Reproductive Endocrinology, Department of Obstetrics and Gynecology | University of California Davis School of Medicine, California USA (2010-2011) |
| Ph.D. | Rey Juan Carlos University of Madrid Medical School, Madrid, Spain (2014) |
Honors and recognition
| First Prize Paper, Society for Reproductive Endocrinology and Infertility | 2016 |
| Ph.D Extraordinary Award, Rey Juan Carlos University of Madrid Medical School Madrid, Spain | 2014 |
| First Prize Poster, American Society for Reproductive Medicine | 2011 |
| Extraordinary Award for Degree in Medicine, Complutense University of Madrid | 2003-2004 |
Publications
-
A 5-year Multicenter Randomized Controlled Trial of In Vitro Fertilization with Personalized Blastocyst Transfer versus Frozen or Fresh Transfer.
Simon C Gomez C Cabanillas S I Vladimirov Castillón J Giles J Boynukalin D Findikli N Bahceci M Ortega I Vidal C Funabiki M Izquierdo A Lopez L S Portela Frantz N Kulmann N Taguchi S Labarta E Colucci F S Mackens X Santamar´?a E Munoz S Barrera García-Velasco JA Fernandez M Ferrando M Ruiz M Valbuena D for the ERA-RCT Study Consortium Group
Reproductive BioMedicine OnlineIn press, journal pre-proofAvailable online 15 June 2020 -
A 5-year Multicenter Randomized Controlled Trial of In Vitro Fertilization with Personalized Blastocyst Transfer versus Frozen or Fresh Transfer.
Simon C Gomez C Cabanillas S I Vladimirov Castillón J Giles J Boynukalin D Findikli N Bahceci M Ortega I Vidal C Funabiki M Izquierdo A Lopez L S Portela Frantz N Kulmann N Taguchi S Labarta E Colucci F S Mackens X Santamar´?a E Munoz S Barrera García-Velasco JA Fernandez M Ferrando M Ruiz M Valbuena D for the ERA-RCT Study Consortium Group
Reproductive BioMedicine OnlineIn press, journal pre-proofAvailable online 15 June 2020 -
Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.
Ortega I García-Velasco JA Pellicer A
J Assist Reprod Genet, 35(10):1751-1762, 2018. -
Sigue habiendo indicaciones para el ciclo natural?
Castro B Ortega I
2017 -
Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.
Ortega I García-Velasco JA Pellicer A
J Assist Reprod Genet, 35(10):1751-1762, 2018. -
Generation of mice with longer and better preserved telomeres in the absence of genetic manipulations
Varela E Muñoz M Tejera M Ortega I Blasco M
Nature Communications, 7: 11739-11755.2016. -
Using donor gametes, embryos.
Iglesias C Ortega I García-Velasco JA
-
High responder: optimizing your stimulation without complications.
Martínez Salazar J Ortega I García-Velasco JA
-
Ovarian actions of resveratrol.
Ortega I Duleba AJ
Ann N Y Acad Sci, 2015. -
Progesterone supplementation in the frozen embryo transfer cycle.
Ortega I García-Velasco JA
Curr Opin Obstet Gynecol. 2015
Read more
Presentations
- Ortega I Alvarez de la Fuente A Sonia Matey Elizabet Henzenn Cruz M Pacheco A Antoni Duleba Garcia-Velasco JA P-854 RESVERATROL FOR PREVENTING OVARIAN HYPERSTIMULATION SYNDROME IN WOMEN AT RISK UNDERGOING EGG DONATION: A RANDOMIZED CONTROLLED STUDY. Presented at 76th American Society of Reproductive Medicine Scientific Congress, Virtual congress, October 17-21,2020
- Simon C Gómez C Cabanillas S Vladimirov IK Castillón G Giles J Boynukalin FK Findikli N Ortega I Vidal C Izquierdo A Portela S Frantz N Taguchi S Labarta E Colucci F Mackens S Santamaría X Muñoz E Barrera SG Fernandez-Sanchez M O-134 IN VITRO FERTILIZATION WITH PERSONALIZED BLASTOCYST TRANSFER VERSUS FROZEN OR FRESH BLASTOCYST TRANSFER: A MULTICENTER, RANDOMIZED CLINICAL TRIAL. Presented at the 35th annual meeting of the European Society of Human Reproduction and Embryology, Vienna, Austria, 14-16 October 2019
Read more